Investor Hub
Novavax, Inc. is a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases.
Latest investor presentation
Annual report
Latest publications, posters & presentations
Global ticker
NASDAQNVAX
NASDAQNVAX
Year
Type
| Form | Description | Date | Format |
|---|---|---|---|
| SC 13D | Filing by person(s) reporting owned shares of common stock in a public company >5% | Dec 29, 2000 |  Open Filing by person(s) reporting owned shares of common stock in a public company >5% in HTML. Open Filing by person(s) reporting owned shares of common stock in a public company >5% in DOC file. Open Filing by person(s) reporting owned shares of common stock in a public company >5% in PDF file. Open Filing by person(s) reporting owned shares of common stock in a public company >5% in XLS file. |
Why invest with us
 |
Get notifications for investor updates
Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings, and more.
Investor inquiries
 |
Shareholders seeking information can contact investor relations at (240) 268-2022 or email us at ir@novavax.com
Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.